ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,756Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 54

$355K Total Retail Price of All Prescriptions

Rank: 21 out of 54

208 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 208 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 7,745 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 409 409 1 3
OMEPRAZOLE 319 319 2 9
AMLODIPINE BESYLATE 284 284 3 4
GABAPENTIN 259 259 4 16
METOPROLOL TARTRATE 259 259 4 7
SIMVASTATIN 244 244 6 5
POLYETHYLENE GLYCOL 3350 243 233 7 37
LISINOPRIL 210 210 8 6
DONEPEZIL HCL 198 198 9 8
MIRTAZAPINE 156 156 10 11
TRAZODONE HCL 156 156 10 10
LEVOTHYROXINE SODIUM 141 141 12 2
ALENDRONATE SODIUM 137 137 13 31
CYMBALTA 133 133 14 26
SERTRALINE HCL 132 132 15 12
NAMENDA 127 127 16 13
DIOVAN 105 105 17 29
CITALOPRAM HBR 102 102 18 17
GLIPIZIDE 97 97 19 47
QUETIAPINE FUMARATE 93 93 20 21
TAMSULOSIN HCL 93 93 20 25
TRAMADOL HCL 87 87 22 32
POTASSIUM CHLORIDE 86 86 23 22
CARVEDILOL 86 86 23 36
HYDROCHLOROTHIAZIDE 83 83 25 20
RISPERIDONE 83 83 25 23
ISOSORBIDE MONONITRATE ER 79 79 27 41
METFORMIN HCL 79 79 27 19
ATENOLOL 74 74 29 24
DIGOXIN 71 71 30 40
LAMOTRIGINE 68 68 31 101
OXYCODONE HCL 66 66 S2 32 57
WARFARIN SODIUM 65 65 33 1
LEVETIRACETAM 63 63 34 46
JANTOVEN 63 63 34 76
PRAVASTATIN SODIUM 58 58 36 27
DIVALPROEX SODIUM 57 57 37 28
ZOLPIDEM TARTRATE 56 56 38 35
OXYCONTIN 55 55 S2 39 125
ALBUTEROL SULFATE 53 53 40 84
VENLAFAXINE HCL ER 52 52 41 74
PLAVIX 50 50 42 59
ADVAIR DISKUS 50 50 42 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.